PCR Journal Club

The results of PREDICT-LAA remain fascinating and point focus on a current topic such as the use of AI models in planning structural cardiac interventions.

A transdermal-infrared spectrophotometric sensor (T-ISS) to assess troponins increase has been recently developed. This multicenter, observational study tested the feasibility of implementing this tool with machine learning analytics carried out in a cohort of patients presenting with acute coronary syndrome.

This position paper concentrated on the diagnosis and management of severe CAD in TAVI candidates, THV commissural alignment, coronary re-access after TAVI, and redo-TAVI.

The OPTIMUM study evaluates the outcomes in patients with complex CAD, including significant LM disease, its equivalent, or MVD CAD, undergoing percutaneous revascularization in addition to guideline directed medical therapy (GDMT) versus GDMT alone.

A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). The current position paper reviews the evidence for the safety and efficacy of renal denervation (RDN), summarizes aspects of the Expert Group’s discussion, and provides consensus statements...

The aim of this study is to present the TMVR results at 2 years from the MITRAL population.

The PREPARE-CALC trial was the first trial that compared lesion preparation using rotational atherectomy (RA) prior to sirolimus-eluting stent (SES) implantation with modified balloons (MB; cutting or scoring) in patients presenting with chronic coronary syndromes.

Population-based studies show a higher prevalence of significant TR in women and following that in published and ongoing trials on TTVI more women than men were enrolled. However, so far it has not been investigated whether such differences in epidemiology also would affect TTVI outcomes...

This pilot study aimed to investigate the feasibility, safety, and efficacy (long-term patency) of the recanalization of chronic RAO via DRA7.

Pediatric patients requiring anticoagulation are a rare but extremely complex subgroup, with congenital (univentricular circulation, Fontan circulation, venous-to-systemic shunts) or acquired diseases (Kawasaki disease), which represents a therapeutic and logistic challenge.